Skip to main content

Animations

MJFF Publications

3981 - 3990 of 8436 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma
    Journal Name: Computational and Structural Biotechnology Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.csbj.2021.09.011
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Stimulation Sweet Spot in Subthalamic Deep Brain Stimulation – Myth or Reality? A Critical Review of Literature
    Journal Name: Stereotactic and Functional Neurosurgery
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000516098
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Subcortical grey matter changes associated with motor symptoms evaluated by the Unified Parkinson’s disease Rating Scale (part III): A longitudinal study in Parkinson’s disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2021.102745
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Targeting mitophagy in Parkinson's disease
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.rev120.014294
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
    Journal Name: Neural Regeneration Research
    Publisher: Medknow
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.4103/1673-5374.303027
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemic
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100107
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The Clinical Value of Patient Home Videos in Movement Disorders
    Journal Name: Tremor and Other Hyperkinetic Movements
    Publisher: Ubiquity Press, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.5334/tohm.651
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The global Alzheimer's Association round robin study on plasma amyloid β methods
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/dad2.12242
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: The Isolation and Deep Sequencing of Mitochondrial DNA
    Journal Name: Methods in Molecular Biology
    Publisher: Springer US
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-0716-1270-5_27
    Best OA location URL:
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.